Related Experiment Video
Updated: May 26, 2026
Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells
Published on: January 28, 2015
Small molecule induction of neural-like cells from bone marrow-mesenchymal stem cells
Ye Wang1, Wenfeng He, Hetao Bian
1Department of Neurology, Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Abstract:
Bone marrow-derived mesenchymal stem cells (MSCs) have been demonstrated to be able to differentiate into neuron-like cell, but the precise mechanisms controlling this process are unclear. We report here that LY294002, a small molecule inhibitor of PI3K/AKT signal pathway, can inhibit proliferation and promote neuronal differentiation of MSCs after MSCs incubated with LY294002 for 6 and 12 h. RT-PCR results indicated that mRNA expression of α5β1 integrin significantly increased in neuron-like cell from MSCs. Interestingly, neuron-like cells derived by this method adhere much more strongly than MSCs, which was related to the expression of α5β1 integrin and FAK phosphorylation. However, these effects could be attenuated by LiCL or GSK-3β-siRNA. Our results indicate that activation GSK-3β signaling may be involved in MSCs proliferation, differentiation, and adhesion. Furthermore, this study demonstrates that small molecule regulators of PI3K/AKT signaling may be valuable tools for stem cell research aimed at treatment of neurodegenerative disease.
Insights
Small molecules inhibiting PI3K/AKT signaling promote neuronal differentiation in mesenchymal stem cells (MSCs). Glycogen synthase kinase-3 beta (GSK-3β) activation is key to MSCs
Area of Science:
- Stem Cell Biology
- Neuroscience
- Molecular Biology
Background:
- Mesenchymal stem cells (MSCs) can differentiate into neuron-like cells, but mechanisms are unclear.
- Understanding MSCs' neuronal differentiation is crucial for neurodegenerative disease treatments.
Purpose of the Study:
- Investigate the role of PI3K/AKT signaling in MSCs' neuronal differentiation.
- Identify key molecular pathways regulating MSCs' differentiation and adhesion.
Main Methods:
- Utilized LY294002, a PI3K/AKT inhibitor, to treat MSCs.
- Performed RT-PCR to analyze gene expression (α5β1 integrin).
- Assessed cell adhesion and FAK phosphorylation.
- Used LiCL and GSK-3β-siRNA to modulate signaling pathways.
Main Results:
- LY294002 inhibited MSC proliferation and promoted neuronal differentiation.
- α5β1 integrin mRNA expression increased in neuron-like cells.
- Enhanced cell adhesion correlated with α5β1 integrin and FAK phosphorylation.
- GSK-3β inhibition attenuated these effects.
Conclusions:
- Activation of GSK-3β signaling is implicated in MSC proliferation, differentiation, and adhesion.
- Small molecule regulators of PI3K/AKT signaling are potential tools for stem cell therapy in neurodegenerative diseases.
More Related Videos
10:16Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells
Published on: June 14, 2017
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
